iX Biopharma Ltd. announced on Dec, 22 2025 that it has issued and allotted 25,040 new ordinary shares pursuant to the exercise of warrants at 0.06 Singapore dollars per share.

Following the allotment, the company’s total issued share capital has risen to 958,050,650 shares, up from 958,025,610 shares. The newly issued shares will rank pari passu with existing shares and are expected to commence trading on the Singapore Exchange Securities Trading Limited around Dec, 24 2025.

To date, 3,091,205 warrants—about 5.38% of all warrants originally issued—have been exercised. A total of 54,418,274 warrants remain outstanding, each carrying an exercise price of 0.06 Singapore dollars and expiring on Jul, 18 2026.

Warrant holders can find exercise instructions at the company’s website.